BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36765717)

  • 1. Potent Inhibition of Macropinocytosis by Niclosamide in Cancer Cells: A Novel Mechanism for the Anticancer Efficacy for the Antihelminthic.
    Sennoune SR; Nandagopal GD; Ramachandran S; Mathew M; Sivaprakasam S; Jaramillo-Martinez V; Bhutia YD; Ganapathy V
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of SLC38A5, an amino acid-coupled Na+/H+ exchanger, in triple-negative breast cancer and its relevance to macropinocytosis.
    Ramachandran S; R Sennoune S; Sharma M; Thangaraju M; V Suresh V; Sneigowski T; D Bhutia Y; Pruitt K; Ganapathy V
    Biochem J; 2021 Nov; 478(21):3957-3976. PubMed ID: 34704597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Oncogenic Changes in p53 and KRAS on Macropinocytosis and Ferroptosis in Colon Cancer Cells and Anticancer Efficacy of Niclosamide with Differential Effects on These Two Processes.
    Nguyen NT; Sennoune SR; Dharmalingam-Nandagopal G; Sivaprakasam S; Bhutia YD; Ganapathy V
    Cells; 2024 May; 13(11):. PubMed ID: 38891084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Oxidative Stress and Ferroptosis in Triple-Negative Breast Cancer Cells by Niclosamide via Blockade of the Function and Expression of SLC38A5 and SLC7A11.
    Mathew M; Sivaprakasam S; Dharmalingam-Nandagopal G; Sennoune SR; Nguyen NT; Jaramillo-Martinez V; Bhutia YD; Ganapathy V
    Antioxidants (Basel); 2024 Feb; 13(3):. PubMed ID: 38539825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unconventional Functions of Amino Acid Transporters: Role in Macropinocytosis (SLC38A5/SLC38A3) and Diet-Induced Obesity/Metabolic Syndrome (SLC6A19/SLC6A14/SLC6A6).
    Bhutia YD; Mathew M; Sivaprakasam S; Ramachandran S; Ganapathy V
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells.
    Pan JX; Ding K; Wang CY
    Chin J Cancer; 2012 Apr; 31(4):178-84. PubMed ID: 22237038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLC38A5 aggravates DC-mediated psoriasiform skin inflammation via potentiating lysosomal acidification.
    Zhu L; Xia X; Li G; Zhu C; Li Q; Wang B; Shi NX; Lei Z; Yang S; Zhang Z; Li H; Tan J; Liu Z; Wen Q; Zhong H; Lin XJ; Sun G; Bao X; Wang Q; Deng L; Bin L; Cao G; Yin Z
    Cell Rep; 2023 Aug; 42(8):112910. PubMed ID: 37531255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino Acid Transporter Slc38a5 Controls Glucagon Receptor Inhibition-Induced Pancreatic α Cell Hyperplasia in Mice.
    Kim J; Okamoto H; Huang Z; Anguiano G; Chen S; Liu Q; Cavino K; Xin Y; Na E; Hamid R; Lee J; Zambrowicz B; Unger R; Murphy AJ; Xu Y; Yancopoulos GD; Li WH; Gromada J
    Cell Metab; 2017 Jun; 25(6):1348-1361.e8. PubMed ID: 28591637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihelminthic drug niclosamide inhibits CIP2A and reactivates tumor suppressor protein phosphatase 2A in non-small cell lung cancer cells.
    Kim MO; Choe MH; Yoon YN; Ahn J; Yoo M; Jung KY; An S; Hwang SG; Oh JS; Kim JS
    Biochem Pharmacol; 2017 Nov; 144():78-89. PubMed ID: 28813646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine-Glycine-One-Carbon Pathways in Cancer.
    Sniegowski T; Korac K; Bhutia YD; Ganapathy V
    Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33806675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity analysis of niclosamide reveals potential role for cytoplasmic pH in control of mammalian target of rapamycin complex 1 (mTORC1) signaling.
    Fonseca BD; Diering GH; Bidinosti MA; Dalal K; Alain T; Balgi AD; Forestieri R; Nodwell M; Rajadurai CV; Gunaratnam C; Tee AR; Duong F; Andersen RJ; Orlowski J; Numata M; Sonenberg N; Roberge M
    J Biol Chem; 2012 May; 287(21):17530-17545. PubMed ID: 22474287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
    Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
    PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC.
    Wang LH; Xu M; Fu LQ; Chen XY; Yang F
    Sci Rep; 2018 Aug; 8(1):12776. PubMed ID: 30143678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma
    Zhou J; Jin B; Jin Y; Liu Y; Pan J
    Theranostics; 2017; 7(6):1447-1462. PubMed ID: 28529629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interdependent regulation of intracellular acidification and SHP-1 in apoptosis.
    Thangaraju M; Sharma K; Liu D; Shen SH; Srikant CB
    Cancer Res; 1999 Apr; 59(7):1649-54. PubMed ID: 10197642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer.
    Lin CK; Bai MY; Hu TM; Wang YC; Chao TK; Weng SJ; Huang RL; Su PH; Lai HC
    Oncotarget; 2016 Feb; 7(8):8993-9006. PubMed ID: 26848771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Blockade of IGF Signaling Sensitizes Human Ovarian Cancer Cells to the Anthelmintic Niclosamide-Induced Anti-Proliferative and Anticancer Activities.
    Deng Y; Wang Z; Zhang F; Qiao M; Yan Z; Wei Q; Wang J; Liu H; Fan J; Zou Y; Liao J; Hu X; Chen L; Yu X; Haydon RC; Luu HH; Qi H; He TC; Zhang J
    Cell Physiol Biochem; 2016; 39(3):871-88. PubMed ID: 27497986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-responsive delivery of anti-metastatic niclosamide using mussel inspired polydopamine nanoparticles.
    Mhatre O; Reddy BPK; Patnaik C; Chakrabarty S; Ingle A; De A; Srivastava R
    Int J Pharm; 2021 Mar; 597():120278. PubMed ID: 33540007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The
    Taurino G; Chiu M; Bianchi MG; Griffini E; Bussolati O
    Am J Physiol Cell Physiol; 2023 Aug; 325(2):C550-C562. PubMed ID: 37458433
    [No Abstract]   [Full Text] [Related]  

  • 20. Entry of a novel marine DNA virus, Singapore grouper iridovirus, into host cells occurs via clathrin-mediated endocytosis and macropinocytosis in a pH-dependent manner.
    Wang S; Huang X; Huang Y; Hao X; Xu H; Cai M; Wang H; Qin Q
    J Virol; 2014 Nov; 88(22):13047-63. PubMed ID: 25165116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.